CIRB Studies
Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
| Study Number | Lead Group | Study Title | CIRB | Study Status |
|---|---|---|---|---|
| S1614 | SWOG | A Phase III Randomized Trial of Prophylactic Antiviral Therapy in Patients with Current or Past Hepatitis B Virus (HBV) Infection Receiving Anti-Cancer Therapy for Solid Tumors | Cancer Prevention and Control CIRB | Available to Open |
| NRG-CC005 | NRG | FORTE (Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps) | Cancer Prevention and Control CIRB | Available to Open |
| A221505 | Alliance | RT Charm: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation with Breast Reconstruction | Cancer Prevention and Control CIRB | Available to Open |
| NRG-CC001 | NRG | A Randomized Phase III Trial Of Memantine And Whole-Brain Radiotherapy With Or Without Hippocampal Avoidance In Patients With Brain Metastases | Cancer Prevention and Control CIRB | Completed |
| A222101 | Alliance | An Early Phase and Phase II Clinical Trial to Evaluate Ganglioside-Monosialic Acid (GM1) for Preventing Paclitaxel-Associated Neuropathy | Cancer Prevention and Control CIRB | Available to Open |
| WF-2300CD | NCORP-Wake Forest University | Practice Survey for Multi-site Community Oncology Planning for the CONNECT Intervention Targeting Lung Cancer Caregivers | Cancer Prevention and Control CIRB | Available to Open |
| WF-30917CD | NCORP-Wake Forest University | A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors | Cancer Prevention and Control CIRB | Available to Open |
| URCC-19085 | NCORP-University of Rochester Cancer Center | Wireless Transcutaneous Electrical Nerve Stimulation (TENS) For Chemotherapy-Induced Peripheral Neuropathy: A Phase II Clinical Trial | Cancer Prevention and Control CIRB | Available to Open |
| MAY2017-09-01 | CP-CTNet_CLO-Mayo Clinic | Phase I Double-Blind, Placebo-Controlled Trial of 27 mg Dolcanatide (SP-333) to Demonstrate Colorectal Bioactivity in Healthy Volunteers | Cancer Prevention and Control CIRB | Completed |
| NWU20-02-01 | CLO-Northwestern University | Surgical Window of Opportunity Study of Megestrol Acetate Compared with Megestrol Acetate and Metformin for Endometrial Intraepithelial Neoplasia | Cancer Prevention and Control CIRB | Available to Open |